Pr Moudouni MD PhD retweeted
Kidney cancer care just got a major upgrade.
The NICE 2026 guideline finally gives a full roadmap for RCC, from diagnosis → treatment → follow-up.
⚙️ What changes in clinic:
🔬 Biopsy matters more
• Recommended for small renal masses (≤4 cm) when it impacts decisions
👀 Active surveillance is legit
• Now standard option for selected small tumors + Bosniak 3 cysts
🔪 Surgery still leads
• Remains gold standard for many localized cases
🔥 Non-surgical options
• Ablation / SABR for patients unfit or unwilling for surgery
📊 Follow-up gets smarter
• Risk-adapted imaging instead of one-size-fits-all
👨⚕️ Team-based care
• Strong push for MDT + clinical nurse specialist access
💡 Takeaway
👉 Less overtreatment, more personalization, better structured RCC care
🔖 This will change real-world practice more than most trials.
📖 Full paper in comment ⬇️
#OncoTwitter #MedTwitter #KidneyCancer #RCC
@OncoAlert @myesmo @esmo_open @asco
Pr Moudouni MD PhD retweeted
#Urologists often overlook bowel symptoms after RC—especially in younger patients and those with neobladders.
These symptoms can seriously impact quality of life. Don’t forget to ask.
Don’t forget to manage.
Pr Moudouni MD PhD retweeted
Hello #urologists!
Don't forget to monitor vitamin B12 levels during follow-up after cystectomy and urinary diversion.
Pr Moudouni MD PhD retweeted
GENOCIDE COMPLICITY teapawt.net/Soureh_design2/status/…






















